Actively Recruiting
China Inherited Ventricular Arrhythmias Registry
Led by China National Center for Cardiovascular Diseases · Updated on 2019-03-26
500
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
Sponsors
C
China National Center for Cardiovascular Diseases
Lead Sponsor
R
Renmin Hospital of Wuhan University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is an observational, prospective, multi-center registry, aiming at building a risk stratification for malignant inherited ventricular arrhythmias, including Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) and Catecholaminergic polymorphic ventricular tachycardia(CPVT). 500 participants will be recruited from 10 centers in China, with clinical data to be abstracted from medical records, and blood samples to be collected for finding related genes and promising risk indicators. The follow-up should be made every 6 months.
CONDITIONS
Official Title
China Inherited Ventricular Arrhythmias Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Brugada syndrome, Long QT syndrome, Short QT syndrome, Early repolarization syndrome, or Catecholaminergic polymorphic ventricular tachycardia.
You will not qualify if you...
- Currently enrolled in other clinical trials.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
China National Center for Cardiovascular Diseases
Beijing, Beijing Municipality, China, 100037
Actively Recruiting
Research Team
Y
Yan YAO, MD,PhD
CONTACT
S
Shangyu LIU, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here